U.S government panel rejects MDMA as PTSD treatment

A U.S Food and Drug Administration panel has rejected the use of MDMA as a treatment for post-traumatic stress disorder. Panelists expressed concern about the quality of the clinical trials used with the drug commonly known as ecstasy or molly. Ira Spitzer reports.

us